These results indicate that SFPs could improve diabetes mellitus, possibly ascribed to the activation of the IRS/PI3K/AKT signaling pathway, inhibition of endogenous glucose production and acceleration of lipid metabolism. The gene discussed is IARS1; the disease is diabetes mellitus.